Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
76 studies found for:    "Schwannoma"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Vestibular Schwannoma and Psychological Factors
Condition: Vestibular Schwannoma
Intervention:
2 Recruiting Vestibular Schwannoma - Radiosurgery or Expectation: V-REX.
Condition: Vestibular Schwannoma
Intervention: Radiation: gamma knife radiosurgery
3 Recruiting Gamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved Hearing, a Prospective Randomized Study
Condition: Vestibular Schwannoma
Intervention: Radiation: Initial Gamma knife radiosurgery
4 Unknown  Stereotactic Radiation in Vestibular Schwannoma
Condition: Vestibular Schwannoma
Interventions: Radiation: stereotactic radiotherapy;   Radiation: stereotactic radiosurgery
5 Completed Assessment of Volumetric Growth Rates of Spinal Intradural Extramedullary Schwannoma
Conditions: Schwannoma;   Neurinoma
Intervention:
6 Recruiting Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function
Condition: Vestibular Schwannoma
Intervention: Drug: Gentamicins
7 Recruiting Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
Condition: Vestibular Schwannoma
Intervention: Drug: Gentamicin
8 Suspended Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannoma
Condition: Vestibular Schwannoma
Intervention: Drug: Bevacizumab (Avastin)
9 Recruiting Preoperative Vestibular Rehabilitation Effectiveness After Vestibular Schwannoma Surgery
Condition: Vestibular Schwannoma
Intervention: Other: Preoperative vestibular rehabilitation
10 Terminated A Study of Nilotinib in Growing Vestibular Schwannomas
Condition: Growing Vestibular Schwannomas
Intervention: Drug: Nilotinib
11 Completed Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma
Condition: Vestibular Schwannoma
Intervention: Drug: gentamicin
12 Recruiting Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Conditions: Neurofibromatosis Type 2;   Vestibular Schwannomas
Intervention: Drug: Axitinib
13 Recruiting Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas
Conditions: Neurofibromatosis Type 2;   Progressive Vestibular Schwannomas
Intervention: Drug: Bevacizumab
14 Recruiting Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
Conditions: Vestibular Schwannoma;   Acoustic Neuroma
Intervention: Radiation: Fractionated proton radiation
15 Completed Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Conditions: Acoustic Schwannoma;   Neurofibromatosis Type 2
Interventions: Biological: bevacizumab;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
16 Recruiting Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
Conditions: Neurofibromatosis Type 2;   Vestibular Schwannomas;   Meningiomas
Intervention: Drug: RAD001
17 Recruiting Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
Conditions: Vestibular Schwannoma;   Meningioma;   Acoustic Neuroma;   Neurofibromatosis Type 2
Intervention: Drug: AR-42
18 Unknown  Concentration and Activity of Lapatinib in Vestibular Schwannomas
Conditions: Vestibular Schwannoma;   NF2;   Neurofibromatosis 2;   Acoustic Neuroma;   Auditory Tumor
Intervention: Drug: lapatinib
19 Completed Alternative Treatment of Giant Spinal Schwannomas
Condition: Spinal Cord Neoplasms
Intervention:
20 Recruiting Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
Conditions: Neurofibromatosis Type 2;   Neuroma, Acoustic
Intervention: Drug: RAD001, everolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.